DNA gyrase subunit B - P0A4L9
Model based on:
Cross-references
REFSEQ | WP_000134039.1; NZ_AKVY01000001.1 | |
---|---|---|
PFAM | PF02518 - HATPase_c; PF00204 - DNA_gyraseB; PF00986 - DNA_gyraseB_C; PF01751 - Toprim | |
KEGG | spn:SP_0806 | |
EMBL | AE005672; AAK74943.1; X83917; CAA58771.1 | |
EC | 5.99.1.3 | |
Drugbank | DB01044 - Gatifloxacin | |
CHEMBL | CHEMBL1075021 |
Gene Ontology
Molecular Function | GO ID | Term | Evidence |
---|---|---|---|
GO:0003677 | F:DNA binding | IEA | |
GO:0003918 | F:DNA topoisomerase type II (ATP-hydrolyzing) activity | IEA | |
GO:0005524 | F:ATP binding | IEA | |
GO:0046872 | F:metal ion binding | IEA | |
Biological Process | GO ID | Term | Evidence |
GO:0006261 | P:DNA-dependent DNA replication | IEA | |
GO:0006265 | P:DNA topological change | IEA | |
GO:0046677 | P:response to antibiotic | IEA | |
Cellular Component | GO ID | Term | Evidence |
GO:0005694 | C:chromosome | IEA | |
GO:0005737 | C:cytoplasm | IEA |
Mutation panel
Mutation | Phenotype | Reference | Map mutation on Model |
---|---|---|---|
S127L | novobiocin | PMID:NA | 102 |
Sequence
Multiple sequence alignment
MSA Mutation
Variant | Position in MSA |
---|---|
S127L | 129 |